Artificial intelligence (AI) is transforming various industries as a major investing theme in 2025. The technology's ability ...
A high drug failure rate is more than just a pattern recognition problem. Here's how we can address some of the root causes.
AI models are able to design molecules that don’t even exist in nature. Some have proven effective as snake antivenom.
Hosted on MSN9d
The AI advantage in discovering new medicinesIn a milestone for science and technology, the 2024 Nobel Prize in Chemistry was awarded to the DeepMind team for their work ...
Harwood works with technology and business leaders to respond to rapid innovation at the intersection of science and technology. His research explores the rise of generative AI and accelerated use of ...
AI is increasingly being adopted across healthcare and in 2025, it will be a driving force behind a smarter, nimbler, and ...
Its deal with the US-based AI-driven drug design and development company will see Cloud design novel small-molecule agents to GSK-specified targets. Ed Addison, CEO of Cloud Pharmaceuticals ...
Modern product engineering requires the production of highly accurate digital simulations, allowing engineers to create ...
DeepSeek-R1 charts a new path for AI through explaining its own reasoning process. Why does this matter and how will it ...
There is growing enthusiasm about China’s potential to speed up drug development with AI. And companies outside the country ...
an AI model trained on billions of natural protein sequences, to design a functional protein beyond evolutionary constraints. The development is expected to accelerate medical research, drug ...
The search for new tuberculosis drug targets under traditional laboratory methods has historically proven to be arduous and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results